标题
TRUCKs: the fourth generation of CARs
作者
关键词
-
出版物
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 15, Issue 8, Pages 1145-1154
出版商
Informa Healthcare
发表日期
2015-05-19
DOI
10.1517/14712598.2015.1046430
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New Cell Sources for T Cell Engineering and Adoptive Immunotherapy
- (2015) Maria Themeli et al. Cell Stem Cell
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- (2015) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- CD19-CAR Trials
- (2014) Carlos A. Ramos et al. CANCER JOURNAL
- Novel Approaches to Enhance the Specificity and Safety of Engineered T Cells
- (2014) Victor D. Fedorov et al. CANCER JOURNAL
- Akt Inhibition Enhances Expansion of Potent Tumor-Specific Lymphocytes with Memory Cell Characteristics
- (2014) J. G. Crompton et al. CANCER RESEARCH
- Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors
- (2014) Daniel W. Beury et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-15.IL-15R complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells
- (2014) F. Tamzalit et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Are natural killer cells superior CAR drivers?
- (2014) Hans Klingemann OncoImmunology
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Exploiting the curative potential of adoptive T-cell therapy for cancer
- (2013) Christian S. Hinrichs et al. IMMUNOLOGICAL REVIEWS
- Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies
- (2013) Marco L. Davila et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Collapse of the Tumor Stroma is Triggered by IL-12 Induction of Fas
- (2013) Sid P Kerkar et al. MOLECULAR THERAPY
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
- (2013) Cor HJ Lamers et al. MOLECULAR THERAPY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- The Third Signal Cytokine IL-12 Rescues the Anti-Viral Function of Exhausted HBV-Specific CD8 T Cells
- (2013) Anna Schurich et al. PLoS Pathogens
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- CAR T cells transform to trucks: chimeric antigen receptor–redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer
- (2012) Markus Chmielewski et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Local Delivery of lnterleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice
- (2012) D. Chinnasamy et al. CLINICAL CANCER RESEARCH
- Evaluation of γ-Retroviral Vectors That Mediate the Inducible Expression of IL-12 for Clinical Application
- (2012) Ling Zhang et al. JOURNAL OF IMMUNOTHERAPY
- An Il12-Il2-Antibody Fusion Protein Targeting Hodgkin's Lymphoma Cells Potentiates Activation Of Nk And T Cells For An Anti-Tumor Attack
- (2012) Tobias Jahn et al. PLoS One
- Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
- (2011) S. Terakura et al. BLOOD
- Long-term proliferation of functional human NK cells, with conversion of CD56dim NK cells to a CD56bright phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12
- (2011) Alexander C. Dowell et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Nitric oxide short-circuits interleukin-12-mediated tumor regression
- (2011) Nejat K. Egilmez et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
- (2011) M. Chmielewski et al. CANCER RESEARCH
- Costimulation by chimeric antigen receptors revisited the T cell antitumor response benefits from combined CD28-OX40 signalling
- (2011) Andreas A. Hombach et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
- (2011) Tangying Lu et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
- (2011) Sid P. Kerkar et al. JOURNAL OF CLINICAL INVESTIGATION
- Improving Adoptive T Cell Therapy by Targeting and Controlling IL-12 Expression to the Tumor Environment
- (2011) Ling Zhang et al. MOLECULAR THERAPY
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
- (2011) M. Kalos et al. Science Translational Medicine
- Tumor-Specific CD8+ T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
- (2010) S. P. Kerkar et al. CANCER RESEARCH
- Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy
- (2010) John S. Bridgeman et al. CURRENT GENE THERAPY
- CD28 cosignalling does not affect the activation threshold in a chimeric antigen receptor-redirected T-cell attack
- (2010) M Chmielewski et al. GENE THERAPY
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
- (2010) V Hoyos et al. LEUKEMIA
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- IL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expression
- (2010) D M Durrant et al. Mucosal Immunology
- IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46
- (2010) Maya Eisenring et al. NATURE IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started